Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer

Radiother Oncol. 2001 Jan;58(1):83-7. doi: 10.1016/s0167-8140(00)00309-1.

Abstract

Background and purpose: To update and summarize the experience at the Massachusetts General Hospital of a treatment program of high-dose preoperative irradiation, surgical re-resection, and intraoperative radiation therapy (IORT) as a salvage treatment for patients with recurrent rectal or rectosigmoid carcinoma.

Patients and methods: From June 1978 to February 1997, the records of 69 patients with locally recurrent rectal carcinomas or rectosigmoid carcinomas without metastases referred for consideration of IORT were reviewed. Forty-nine patients received IORT and local control and disease-free survival curves were calculated using the actuarial method of Kaplan-Meier.

Results: The 5-year overall survival, local control and disease-free survival rates of 49 patients receiving IORT were 27, 35, and 20%, respectively. Thirty-four patients who underwent a macroscopic complete resection had a significantly better 5-year overall survival than the remaining 15 patients with gross residual disease (33 vs. 13%, P=0.05, log rank). For those patients, local control and disease-free survival rates were 46 and 27%, respectively. Patients with a microscopic complete resection had a superior 5-year overall survival than partially resected patients (40 vs. 14%, P=0.0001, log rank). Chemotherapy had no significant influence on overall or disease-free survival.

Conclusion: The current analysis shows the importance of a microscopic complete resection in a multi-modality approach with IORT for survival and local control. Salvage is rare for patients undergoing subtotal resection.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / pathology
  • Adenocarcinoma / radiotherapy*
  • Adenocarcinoma / surgery
  • Antimetabolites, Antineoplastic / therapeutic use
  • Combined Modality Therapy
  • Disease-Free Survival
  • Dose-Response Relationship, Radiation
  • Fluorouracil / therapeutic use
  • Humans
  • Intraoperative Care
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / radiotherapy*
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Preoperative Care
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / radiotherapy*
  • Rectal Neoplasms / surgery
  • Salvage Therapy
  • Sigmoid Neoplasms / drug therapy
  • Sigmoid Neoplasms / pathology
  • Sigmoid Neoplasms / radiotherapy*
  • Sigmoid Neoplasms / surgery

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil